Glaxosmithkline Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	Glaxosmithkline Phar	Ajanta Pharma	Ipca Laboratories
Operational Metrics
Pharmaceuticals
Domestic Sales Growth - YoY	7.5 %	7.5 %	11.1 %
R&D as a % of Total Sales	0.07 %	5.0 %	3.12 %
Financials
5 yr Average ROE	45.03 %	21.93 %	13.55 %
5yr average Equity Multiplier	1.87	1.33	1.52
5yr Average Asset Turnover Ratio	0.92	0.86	0.76
5yr Avg Net Profit Margin	27.88 %	19.12 %	11.88 %
Price to Book	17.62	8.77	5.09
P/E	38.57	37.6	35.97
5yr Avg Cash Conversion Cycle	-107.65 Days	-104.16 Days	54.3 Days
Inventory Days	47.69 Days	45.5 Days	102.83 Days
Days Receivable	24.45 Days	49.07 Days	72.68 Days
Days Payable	155.09 Days	180.12 Days	111.38 Days
5yr Average Interest Coverage Ratio	556.84	103.83	50.79
5yr Avg ROCE	48.35 %	28.04 %	17.31 %
5yr Avg Operating Profit Margin	27.99 %	25.85 %	19.8 %
5 yr average Debt to Equity	0.0	0.01	0.17
5yr CAGR Net Profit	-9.37 %	8.18 %	-8.34 %
5yr Average Return on Assets	24.4 %	16.5 %	9.41 %
Shareholdings
Promoter Holding	75.0 %	66.25 %	44.72 %
Share Pledged by Promoters	0.0	17.94 %	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.14 %	-1.57 %
Change in Mutual Fund Holding (3 Yrs)	0.77 %	1.45 %	1.3 %

Business

	Glaxosmithkline Phar	Ajanta Pharma	Ipca Laboratories
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 76.0 Vaccines 24.0 Pharmaceutical products 0 API 0 Generics 0 Branded Generics 0	Product Wise Break-Up Branded Generics 0 API 0 Vaccines 0 Generics 0 Pharmaceutical 0 Pharmaceutical 100.0	Product Wise Break-Up Branded Generics 50.39 Active Pharmaceutical Ingredient (API) 16.53 Vaccines 0 Formulations 33.08 Pharmaceutical 0 Pharmaceutical products 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Dermatology 30.55 Anti-Infective 22.25 Vaccines 12.64 Pain Management 11.96 Hormones 8.91 Vitamins / Minerals / Nutrients 6.47 Respiratory 3.95 Pain 0 Neutraceuticals 0 Urology 0 Cough Preparations 0 Neuro Psychiatry 0 Gastro-Intestinal (GI) Products 0 Anti-Bacterials 0 Anti-Malarials 0 Cardiovasculars & Anti-Diabetics 0 0 Others 3.27	Therapeutic Area Wise Break-Up - Domestic Anti-Infective 0 Anti-Malarials 0 Cardiovasculars & Anti-Diabetics 0 Pain Management 0 Hormones 0 Pain 10.0 Neutraceuticals 0 Vitamins / Minerals / Nutrients 0 Vaccines 0 Urology 0 Cough Preparations 0 Neuro Psychiatry 0 Gastro-Intestinal (GI) Products 0 0 Dermatology 22.0 Anti-Bacterials 0 Respiratory 0 Others 68.0	Therapeutic Area Wise Break-Up - Domestic Anti-Infective 0 Anti Malarials 3.0 Cardiac Science 17.0 Pain Management 0 Hormones 0 Pain 53.0 Neutraceuticals 1.0 Vitamins / Minerals / Nutrients 0 Vaccines 0 Urology 5.0 Cough and colds 4.0 Central Nervous System (CNS) 3.0 Gastro Intestinal 2.0 0 Dermatology 6.0 Anti-bacterial 5.0 Respiratory 0 Others 1.0
Location Wise Break-Up	Location Wise Break-Up India 98.64 Rest of the World 1.36 Asia 0 Africa 0 USA 0 Asia (Excluding India) 0 Australia 0 CIS 0 Europe 0	Location Wise Break-Up CIS 0 Europe 0 Africa 16.28 India 28.59 Asia (Excluding India) 0 Asia Pacific 19.39 Rest of the World 0 Australia 0 USA 35.74	Location Wise Break-Up CIS 2.91 Europe 15.68 Africa 6.72 India 44.73 Asia Pacific 5.18 Asia 0 Rest of the World 0 Australia 3.2 USA 21.58
Acute vs Chronic	Acute vs Chronic Acute 99.0 Chronic 1.0	-	-

Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd.

Financial

Business

SIGN UP FOR FREE